Navigation Links
PharmAthene to Delay Release of Full Year 2007 Financial Results
Date:3/20/2008

ANNAPOLIS, Md., March 20 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, today reported the company will delay its earnings release for the full year ended December 31, 2007. The earnings release was previously scheduled for today, March 20, 2008. PharmAthene will schedule the new date and time of its earnings release and conference call at a later time.

The conference call originally scheduled to discuss earnings will occur at 4:30 pm E.T. today and will focus on the Avecia acquisition announced earlier today.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
2. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
3. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
4. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
7. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
10. Flurizans Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimers Disease is Superior to That of Aricept
11. Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2020)... , ... March 12, 2020 , ... ... atomic force microscopy (AFM) technology, increases the business investment in Europe by inaugurating ... , The Grand Opening Ceremony of the new Nanoscience Center Europe took place ...
(Date:3/10/2020)... ... March 10, 2020 , ... Lifecycle Biotechnologies announced today ... Cleburne, Texas to be used as a biopharmaceutical and biotechnology production and development campus. ... offices as well as its production and development hub. The company expects to relocate ...
(Date:3/3/2020)... ... March 03, 2020 , ... Frictionless Solutions, a specialized ... industries, was recognized by INC. 5,000 on an annual list of America’s fastest ... leaders greatly impacting their spheres of influence and experiencing considerable development. INC. 5,000’s ...
(Date:2/28/2020)... ... February 26, 2020 , ... Designed primarily for ... with a dedicated controller, thus simplifying setup, streamlining integration, and optimizing workflow. Capable ... first of Fastec Imaging’s new HS Series cameras to be released. The HS ...
Breaking Biology Technology:
(Date:3/3/2020)... ... March 03, 2020 , ... Board-certified oral and maxillofacial surgeon, Dr. Michael Noffze ... of training and experience, Dr. Noffze can successfully extract problem and impacted wisdom teeth ... possible is beneficial to the oral and overall health of most patients as these ...
(Date:3/2/2020)... ... March 02, 2020 , ... Nominations are now being accepted for the ... Security Industry Association (SIA) and SecureIDNews and co-presented with sponsors ... . The recipients of this year’s Women in Biometrics Awards will be honored at ...
(Date:2/28/2020)... Kan. (PRWEB) , ... February ... ... proudly announces that its patent-pending Rebound PRP™ and Rebound PRF® devices are ... university-validated a new generation of regenerative medical devices, that will provide the ...
Breaking Biology News(10 mins):